After Hours
$
17.55
Change
-1.28 -6.80%
Volume
Volume 729
Mar 3, 2021, 5:17 p.m.
Quotes are delayed by 20 min
Today's close
$ 18.34
$ 18.83
Change
+0.49 +2.67%
Day low
Day high
$17.72
$19.13

52 week low
52 week high
$2.20
$29.99

Market cap
$246.64M
Average volume
392,009
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-0.97
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on INMB
-
INmune Bio stock price target raised to $32 from $16 at Maxim Group
- Tomi Kilgore
-
INmune Bios started at buy with $13 stock price target at Maxim Group
- Tomi Kilgore
Other News on INMB
-
PTON ,U among premarket losers
- Seeking Alpha
-
CLSN, RIOT, POLA and MARA among midday movers
- Seeking Alpha
-
JAGX, TELL, CRDF and DTIL among premarkets gainers
- Seeking Alpha
-
- Seeking Alpha
-
INmune Bio (INMB) Investor Presentation - Slideshow
- Seeking Alpha
-
INmune Bio receives patent for covering INKmune therapy
- Seeking Alpha
-
INmune Bio nabs European patent for XPro1595
- Seeking Alpha
-
HTBX, DGLY, CLNY and RYCE among midday movers
- Seeking Alpha
-
- Seeking Alpha
-
- Seeking Alpha
-
INmune Bio: Stronger Support From Alzheimer's Drug XPro1595
- Seeking Alpha
-
TCDA, NCLH among premarket losers
- Seeking Alpha
-
ZYXI, IMV among premarket losers
- Seeking Alpha
- Loading more headlines...
Press Releases on INMB
-
InvestorNewsBreaks - INmune Bio Inc. (NASDAQ: INMB) Featured by M-Vest
- Investor Brand Network
-
European Patent Granted Covering INmune Bio's XPro1595
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com